News

Dexpramipexole, initially developed by Knopp Biosciences, is a novel drug which prevents dysfunction of mitochondria, the subcellular structures that provide most of a cell’s energy. The researchers devised

T89, also known as Dantonic pill, is a botanical product used to treat chronic stable angina pectoris due to coronary heart disease and aims to become the first

Erwinaze is an asparaginase enzyme which depletes asparagine level in the bloodstream. Asparagine helps in cell growth, and its removal from the blood inhibits the growth of cells

Under the terms of the agreement, Valeant will pay iNova shareholders A$625m ($623.39) upfront and up to an additional A$75m ($74.81) in potential milestones. Valeant Pharmaceuticals develops, manufactures

The deal is expected to strengthen Lupin’s presence in the Japanese market. Lupin president (Asia Pacific, Middle East, Africa and Latin America) Vinod Dhawan said the acquisition would

TNX-102 is a bedtime gelcap with very low dose cyclobenzaprine, which aids in faster and improved absorption as compared to conventional cyclobenzaprine products. The single-dose open-label randomised three-way-crossover

Eylea is a recombinant fusion protein, that binds VEGF-A and placental growth factor (PlGF) to inhibit the binding and activation of these cognate VEGF receptors. The recommended dose

The therapies include Onbrez Inhalation Capsules 150 mcg (indacaterol maleate) and the investigational drugs NVA237 (glycopyrronium bromide) and QVA149 (fixed-dose combination of indacaterol maleate and glycopyrronium bromide). NVA237and

The move indicates that in patients with unknown or negative Rearranged during Transfection (RET) mutation, a lower benefit should be considered prior to individual treatment decisions. Clinical data